secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telesis Bio Inc. (—)
CIK:        0001850079
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0000950170-24-053596
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Telesis Bio approves 1-for-18 reverse stock split to regain Nasdaq bid price compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-18 ratio approved by stockholders on May 1, 2024; effective May 9, 2024.
- Outstanding shares reduced from ~30.1M to ~1.7M; authorized shares remain at 100M.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
- Ticker TBIO unchanged; new CUSIP 192003200; fractional shares rounded up to whole share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850079/000095017024053596/0000950170-24-053596-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850079/000095017024053596/tbio-20240501.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-053596

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer